Singular Wings Medical is proud to announce that the company has obtained a new patent in Taiwan, marking another important milestone in the advancement of our non-invasive health monitoring technologies.
The patent — “Methods and Computing Devices for Non-Invasive Blood Glucose Estimation, Devices for Non-Invasive ECG Signal Measurement, and Non-Transitory Computer-Readable Recording Media” (Taiwan Patent No. 916724) — recognizes our continued innovation in sensing technologies and algorithm development.
This patented technology further strengthens our capabilities in non-invasive blood glucose estimation and non-invasive ECG acquisition, enabling accurate physiological insights without the discomfort associated with traditional methods.
The granting of this patent reinforces Singular Wings Medical’s global intellectual property portfolio and underscores our commitment to driving innovation in preventive and digital healthcare.
